Private Equity

Millions of Americans face a hidden tax threat within their retirement accounts. A new book by financial professionals details the risks and offers strategies.

As Vivos Therapeutics pitches its revolutionary sleep apnea solution to investors, it's not just selling a device; it's fighting for its financial life.

With a complex $72M financing deal, Park Systems is doubling down on its dominance in nanometrology. Is this the move that makes them indispensable to chip giants?

Leilani Farha’s Massey Lectures put the financialization of housing on trial, exposing a system where homes are assets and displacement is profit.

Cadogan Tate's acquisition of a Phoenix specialist isn't just a deal; it's a masterclass in building a global network for the ultra-wealthy.

The firm's high-level hires from rival firms signal a calculated move to dominate the lucrative credit and opportunistic investment landscape amid market shifts.

With a new $4.3B war chest, Hunter Point Capital is evolving from a GP stakes firm into a scaled solutions platform, meeting a critical need for liquidity.

After years of stabilization, a 90% stake in real estate firm DEMIRE is for sale. The move by Apollo and Wecken & Cie. could reshape the firm and signal a market shift.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

Ares Capital, a giant in middle-market finance, just opened a new $1B funding spigot. Is this a blueprint for the BDC industry or a sign of cheaper capital for American businesses?

EQT appoints M&A mastermind Gustav Segerberg as CFO, signaling a doubling-down on its aggressive growth strategy. What does this mean for its future?

A Toronto meeting signals a new era for Canada-Grenada ties. It's a calculated move into geothermal energy, regional security, and high-value trade.

A new study on hedge fund titans reveals a startling truth: in the age of AI, a dense narrative of books and ideas matters more than assets under management.

Blink Charging is selling its Envoy subsidiary to focus on core infrastructure. This isn't just a deal; it's a sign that the EV industry's era of frantic growth is giving way to a new mandate: profitability.

As Royalty Pharma prepares for a key investor conference, we explore the powerful, low-profile business model that funds blockbuster drugs and shapes innovation.

HELP USA's recent gala honored leaders in housing, but the real story is the innovative fusion of finance, policy, and healthcare creating scalable solutions.

A new breed of fund offers Main Street a taste of Silicon Valley's private unicorns. But as Powerlaw Corp. opens the door, are investors ready for the risks?

A $90M investment in a homeless shelter is more than charity; it's a blueprint. Sun Life's model signals a shift from philanthropy to strategic impact investing.

T. Rowe Price's latest podcast challenges the cult of short-term gains, arguing that true investment skill lies in process, self-awareness, and discipline.

The hiring of Ricardo Gonzalez is more than a new CEO. It’s a calculated move by private equity firm ATL Partners to build a defense tech powerhouse.